Dreyer v. United States Department of Justice Drug Enforcement Administration

CourtDistrict Court, S.D. New York
DecidedMarch 24, 2025
Docket1:23-cv-09407
StatusUnknown

This text of Dreyer v. United States Department of Justice Drug Enforcement Administration (Dreyer v. United States Department of Justice Drug Enforcement Administration) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Dreyer v. United States Department of Justice Drug Enforcement Administration, (S.D.N.Y. 2025).

Opinion

UNITED STATES DISTRICT COURT DOC #: SOUTHERN DISTRICT OF NEW YORK DATE FILED: 3/24/2 025 DANIELLE DREYER, Plaintiff, -against- UNITED STATES DEPARTMENT OF 1:23-cv-09407-MKV JUSTICE, Pamela Bondi, as Attorney General of the U.S. Department of Justice, UNITED ORDER GRANTING MOTION TO STATES DRUG ENFORCEMENT DISM ISS ADMINISTRATION, and ANNE MILGRAM, as Administrator of the United States Drug Enforcement Administration Defendants, Defendants. MARY KAY VYSKOCIL, United States District Judge: Plaintiff, Danielle Dreyer, brings this action against the United States Department of Justice (the “DOJ”), the United States Drug Enforcement Administration (the “DEA”), Pamela Bondi,1 as Attorney General of the United States, and Anne Milgram, as Administrator of the DEA. Dreyer raises claims under Title VII of the Civil Rights Act of 1964 (“Title VII”), the New York Human Rights Law (“NYSHRL”), the Civil Service Reform Act of 1978 (“CSRA”), and the Whistleblower Protection Act (“WPA”). [ECF No. 27] (“Second Amended Complaint” or “SAC”). Defendants move to dismiss the case or, in the alternative, for summary judgment. [ECF No. 42]. For the reasons set forth below, the motion to dismiss is GRANTED.

1 Pursuant to Federal Rule of Civil Procedure 25(d), Attorney General Pamela Bondi is automatically substituted for former Attorney General Merrick B. Garland as Defendant. FACTUAL BACKGROUND2 Danielle Dreyer was employed by the DEA for over a decade before she was terminated in 2023. SAC ¶¶ 21, 93. In September 2017, she was directed by her supervisor Mr. Aaron Koger to accompany him to attend a case-related meeting in Cartagena, Colombia (the “Cartagena trip”).

SAC ¶ 22. While in Cartagena, Plaintiff was invited to the home of Jose Irizarry, a DEA employee stationed at the Cartagena DEA office. SAC ¶¶ 23, 24. Several other DEA and law enforcement officers were also invited to the event at Irizarry’s home. SAC ¶¶ 23. At Irizarry’s home, Plaintiff Irizarry and his wife made attempts to sexually seduce Plaintiff, making sexual suggestions and innuendo. SAC ¶ 25. Irizarry’s wife also gave Dreyer a blue pill that Dreyer did not ingest. SAC ¶¶ 26–27. That night Dreyer entered the pool and hot tub at Irizarry’s house topless and wearing only underwear. SAC ¶ 27. Other people entered the pool and hot tub nude as well. SAC ¶ 28. While in the hot tub Dreyer consensually kissed and embraced a woman who was a federal prosecutor and expressed her own lactating breast. SAC ¶¶ 28–29. The next day Dreyer attended another

event hosted by Irizarry and his wife on his boat and received another blue pill from Irizarry which she did not ingest. SAC ¶¶ 30-33. Plaintiff left Cartagena soon thereafter. SAC ¶ 42. Several years later, the FBI began investigating Irizarry and his wife and arrested them for drug trafficking and laundering money (the “Irizarry Investigation”). SAC ¶¶ 44–45. They both plead guilty and began cooperating with the DOJ and DEA. SAC ¶ 47. On January 25, 2022 Plaintiff was ordered to appear at “HQ” and was questioned by Inspector Uhl of the Office of Professional Responsibility (“OPR”) regarding the Cartagena trip. SAC ¶¶ 51–52. During the questioning, OPR Inspector Uhl yelled at Plaintiff, attacked Plaintiff’s character, integrity, sexual

2 The facts as stated herein are drawn from Plaintiff’s Second Amended Complaint and for purposes of this motion, are accepted as true. See Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009). orientation, and gender. SAC ¶ 54. He, in front of others, ridiculed, demeaned, and embarrassed Plaintiff about her bisexual conduct with former the female federal prosecutor at Irizarry’s house and her lactating breasts. Id. Other government employees who had been attendees at Irizarry’s events during the Cartagena trip were interviewed but were not required to appear at HQ or

harassed and ridiculed. SAC ¶ 55. In February 2022, Plaintiff again was contacted by an OPR inspector who alleged that she misplaced three cell phones and a fitness type band/watch which were evidence in a three-year- old case that she had investigated. SAC ¶¶ 57–59. Plaintiff’s acting supervisor told her to forge a federal prosecutor’s signature on a form accounting for the evidence and she refused. SAC ¶¶ 62, 65–66. In April 2022, the DEA put Dreyer on administrative leave for ten days, revoked her security clearance. confiscated her gun, badge and identification, and prohibited her from entering the DEA office without an escort and an official duty order to enter. SAC ¶ 71. Dreyer was told that she was put on leave due to allegations made against her during the Irizarry Investigation and

her actions during the Cartagena trip. Id. Nearing the end of her ten days of leave, Dreyer’s supervisor told her to “stay home till next step.” SAC ¶¶ 72, 73. A few days later, the DEA confiscated Dreyer’s government vehicle and office parking pass. SAC ¶ 74. Throughout May and June 2022, Dreyer was prohibited from returning to work. SAC ¶¶ 75, 76. By July, Plaintiff received a memo notifying her that she was indefinitely suspended without pay. SAC ¶ 76. Dreyer first contacted the DEA Equal Employment Opportunity (“EEO”) officer regarding her complaints in June 2022. SAC ¶ 13. In July 2022, the EEO officer initially interviewed Dreyer and the DEA issued a memo notifying Dreyer of an indefinite suspension without pay. SAC ¶ 13– 14. On August 2, 2022, Dreyer filed an EEO complaint alleging workplace discrimination and

other prohibited personnel practices. SAC ¶¶ 15, 77. Specifically, the complaint alleged that the DEA discriminated against her on the basis of sex and sexual orientation through the following actions: the DEA pretextually accused Dreyer of misplacing evidence in an investigation; a supervisor instructed Dreyer to forge an AUSA’s signature regarding that missing evidence; several DEA employees “ridiculed, harassed, demeaned, and embarrassed” her during an interview

at HQ regarding the Cartagena trip; the DEA suspended Dreyer’s security clearance; and indefinitely suspended her without pay and without a hearing. Osmond Decl. Ex. D (“EEO Complaint”).3 Plaintiff alleges that she was treated disparately based on her sexual orientation because other DEA employees who had attended the parties thrown on the Cartagena trip were not harassed or ridiculed, required to appear in HQ, or punished in any way. Id. Thereafter, Plaintiff received an official mandatory drug screening notice that she was randomly selected to appear at the office from which she was banned. SAC ¶ 78. Dreyer notified her supervisor of the date and time she planned to appear for the drug test and the supervisor replied “go for it.” SAC ¶¶ 80–81. Dreyer met her “supervisory escort,” Sara Dunlea, at the office and Ms. Dunlea escorted Dreyer into and out of the office to facilitate the drug test. SAC ¶ 83. On or

about the same date as the drug test, Dreyer learned that DEA Headquarters Counsel advised the New York office that “it won’t be good for our case if she passes her drug test.’” SAC ¶ 84. Special Agent in Charge (“SAC”) Frank Tarentino also asked the OPR to find that Dreyer and her escort Dunlea had committed misconduct, but was rebuffed. SAC ¶ 85. On April 26, 2023, Plaintiff received a Deciding Official’s Decision Letter of Removal notifying her of her termination. SAC ¶ 93; Osmond Decl. Ex. H. (“Letter of Removal”)]. The Letter of Removal terminated Dreyer based on her actions during the Cartagena trip and other allegations related to the Irizarry Investigation. SAC ¶ 93. On May 16, 2023, Plaintiff filed a

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Brown v. General Services Administration
425 U.S. 820 (Supreme Court, 1976)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Bonds v. Leavitt
629 F.3d 369 (Fourth Circuit, 2011)
Segar v. Mukasey
508 F.3d 16 (D.C. Circuit, 2007)
Natalia Makarova v. United States
201 F.3d 110 (Second Circuit, 2000)
Kloeckner v. Solis
133 S. Ct. 596 (Supreme Court, 2012)
Cheryl Slingland v. Postmaster General
542 F. App'x 189 (Third Circuit, 2013)
Ximines v. George Wingate High School
516 F.3d 156 (Second Circuit, 2008)
Mathirampuzha v. Potter
548 F.3d 70 (Second Circuit, 2008)
Williams v. McCausland
791 F. Supp. 992 (S.D. New York, 1992)
Wilson v. U.S. Department of Transportation
759 F. Supp. 2d 55 (District of Columbia, 2011)
Wajilam Exports (Singapore) Pte. Ltd. v. ATL Shipping Ltd.
475 F. Supp. 2d 275 (S.D. New York, 2006)
Taylor v. Mabus
685 F. Supp. 2d 94 (District of Columbia, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
Dreyer v. United States Department of Justice Drug Enforcement Administration, Counsel Stack Legal Research, https://law.counselstack.com/opinion/dreyer-v-united-states-department-of-justice-drug-enforcement-nysd-2025.